Aurinia Pharmaceuticals Inc. (AUPH) vs Fortrea Holdings Inc. (FTRE)
A side-by-side comparison of Aurinia Pharmaceuticals Inc. and Fortrea Holdings Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AUPH
Aurinia Pharmaceuticals Inc.
$15.78HealthcareDelayed quote: Oct 6, 2026, 11:35 AM EDT
FTRE
Fortrea Holdings Inc.
$21.80HealthcareDelayed quote: Oct 6, 2026, 11:35 AM EDT
Total return — AUPH vs FTRE
growth of $100 · dividends reinvested · last 3yAUPH +58.3% (+16.5%/yr)FTRE -34.0% (-12.9%/yr)AUPH compounded faster over this window
AUPH FTRE
AUPH vs FTRE: by the numbers
- •FTRE is the larger company ($2.07B vs $2.03B market cap).
- •AUPH is profitable (100.84% net margin) while FTRE runs a net loss (-3.18%).
- •AUPH grew revenue faster over the past five years (40.17% vs 1.09% CAGR).
Metrics side by side
Valuation
| Metric | AUPH | FTRE |
|---|---|---|
| P/E ratio | 6.89 | N/A |
| Forward P/E | 16.72 | 25.92 |
| P/S ratio | 6.51 | 0.77 |
| P/B ratio | 3.30 | 3.95 |
| EV / EBITDA | 11.23 | 33.84 |
| FCF yield | 8.55% | 7.26% |
Profitability
| Metric | AUPH | FTRE |
|---|---|---|
| Gross margin | 90.36% | 17.11% |
| Operating margin | 37.06% | 0.41% |
| Net margin | 100.84% | -3.18% |
| ROE | 51.09% | -16.25% |
| ROIC | 21.77% | 0.62% |
Growth (annualized)
| Metric | AUPH | FTRE |
|---|---|---|
| Revenue CAGR (5Y) | 40.17% | 1.09% |
| FCF CAGR (5Y) | N/A | -12.98% |
| Total return CAGR (5Y) | -5.88% | N/A |
Frequently asked
- Which has grown faster, AUPH or FTRE?
- Over the past five years, AUPH grew revenue faster — AUPH at a 40.17% CAGR versus FTRE at 1.09%.
- Is AUPH or FTRE more profitable?
- AUPH runs the higher net margin — AUPH at 100.84% versus FTRE at -3.18%.
Go deeper
Dig into the metrics
Aurinia Pharmaceuticals P/E ratioAurinia Pharmaceuticals ROEFortrea ROEAurinia Pharmaceuticals operating marginFortrea operating marginAurinia Pharmaceuticals revenue growthFortrea revenue growthAurinia Pharmaceuticals free cash flowFortrea free cash flow
Aurinia Pharmaceuticals & Fortrea appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.